HEADER TRANSFERASE 23-JUL-15 5CT7 TITLE BRAF IN COMPLEX WITH RAF265 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE B-RAF; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN (UNP RESIDUES 445-723); COMPND 5 SYNONYM: PROTO-ONCOGENE B-RAF,P94,V-RAF MURINE SARCOMA VIRAL ONCOGENE COMPND 6 HOMOLOG B1; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRAF, BRAF1, RAFB1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR B.A.APPLETON REVDAT 3 06-MAR-24 5CT7 1 REMARK REVDAT 2 07-OCT-15 5CT7 1 JRNL REVDAT 1 09-SEP-15 5CT7 0 JRNL AUTH T.E.WILLIAMS,S.SUBRAMANIAN,J.VERHAGEN,C.M.MCBRIDE, JRNL AUTH 2 A.COSTALES,L.SUNG,W.ANTONIOS-MCCREA,M.MCKENNA,A.K.LOUIE, JRNL AUTH 3 S.RAMURTHY,B.LEVINE,C.M.SHAFER,T.MACHAJEWSKI,P.A.RENHOWE, JRNL AUTH 4 B.A.APPLETON,P.AMIRI,J.CHOU,D.STUART,K.AARDALEN,D.POON JRNL TITL DISCOVERY OF RAF265: A POTENT MUT-B-RAF INHIBITOR FOR THE JRNL TITL 2 TREATMENT OF METASTATIC MELANOMA. JRNL REF ACS MED.CHEM.LETT. V. 6 961 2015 JRNL REFN ISSN 1948-5875 JRNL PMID 26396681 JRNL DOI 10.1021/ML500526P REMARK 2 REMARK 2 RESOLUTION. 3.17 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.17 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.91 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 16811 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.160 REMARK 3 FREE R VALUE TEST SET COUNT : 868 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 3.17 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.39 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.43 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2916 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2180 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2754 REMARK 3 BIN R VALUE (WORKING SET) : 0.2162 REMARK 3 BIN FREE R VALUE : 0.2455 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.56 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 162 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4010 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 74 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 73.59 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.32180 REMARK 3 B22 (A**2) : 5.32180 REMARK 3 B33 (A**2) : -10.64370 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.577 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 2.070 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.335 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 1.679 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.339 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.930 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.896 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4178 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5664 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1444 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 90 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 669 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4178 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 541 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4883 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.13 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.86 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.07 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -15.7785 10.6126 0.7887 REMARK 3 T TENSOR REMARK 3 T11: -0.2000 T22: -0.0728 REMARK 3 T33: 0.0154 T12: -0.0002 REMARK 3 T13: -0.0085 T23: 0.1557 REMARK 3 L TENSOR REMARK 3 L11: 2.9335 L22: 1.9503 REMARK 3 L33: 2.3655 L12: -0.9706 REMARK 3 L13: 2.2481 L23: -0.5722 REMARK 3 S TENSOR REMARK 3 S11: 0.1278 S12: -0.2595 S13: -0.3166 REMARK 3 S21: 0.1504 S22: 0.0970 S23: 0.2542 REMARK 3 S31: 0.0426 S32: -0.0908 S33: -0.2248 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): -39.7093 30.0595 -14.3894 REMARK 3 T TENSOR REMARK 3 T11: -0.2048 T22: -0.0355 REMARK 3 T33: 0.0227 T12: 0.0061 REMARK 3 T13: 0.0066 T23: 0.1065 REMARK 3 L TENSOR REMARK 3 L11: 2.5818 L22: 1.7441 REMARK 3 L33: 1.9617 L12: -1.4752 REMARK 3 L13: 1.0748 L23: -1.3975 REMARK 3 S TENSOR REMARK 3 S11: 0.0289 S12: -0.1829 S13: -0.1953 REMARK 3 S21: -0.0576 S22: 0.1337 S23: 0.1488 REMARK 3 S31: -0.1232 S32: -0.0796 S33: -0.1625 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5CT7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-JUL-15. REMARK 100 THE DEPOSITION ID IS D_1000212143. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-NOV-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16841 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.170 REMARK 200 RESOLUTION RANGE LOW (A) : 48.910 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : 0.11800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.17 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.29 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 7.20 REMARK 200 R MERGE FOR SHELL (I) : 0.72000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.71 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% PEG8000, 0.1 M NACL, AND 0.1 M REMARK 280 TRIS PH 8.4, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.06500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 54.69000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 54.69000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 39.53250 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 54.69000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 54.69000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 118.59750 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 54.69000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 54.69000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 39.53250 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 54.69000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 54.69000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 118.59750 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 79.06500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 443 REMARK 465 SER A 444 REMARK 465 ASP A 445 REMARK 465 SER A 446 REMARK 465 SER A 447 REMARK 465 ASP A 448 REMARK 465 THR A 599 REMARK 465 VAL A 600 REMARK 465 LYS A 601 REMARK 465 SER A 602 REMARK 465 ARG A 603 REMARK 465 TRP A 604 REMARK 465 SER A 605 REMARK 465 GLY A 606 REMARK 465 SER A 607 REMARK 465 HIS A 608 REMARK 465 GLN A 609 REMARK 465 PHE A 610 REMARK 465 GLU A 611 REMARK 465 GLN A 612 REMARK 465 LEU A 613 REMARK 465 SER A 614 REMARK 465 PRO A 722 REMARK 465 LYS A 723 REMARK 465 GLY B 443 REMARK 465 SER B 444 REMARK 465 ASP B 445 REMARK 465 SER B 446 REMARK 465 SER B 447 REMARK 465 ASP B 448 REMARK 465 GLY B 596 REMARK 465 LEU B 597 REMARK 465 ALA B 598 REMARK 465 THR B 599 REMARK 465 VAL B 600 REMARK 465 LYS B 601 REMARK 465 SER B 602 REMARK 465 ARG B 603 REMARK 465 TRP B 604 REMARK 465 SER B 605 REMARK 465 GLY B 606 REMARK 465 SER B 607 REMARK 465 HIS B 608 REMARK 465 GLN B 609 REMARK 465 PHE B 610 REMARK 465 GLU B 611 REMARK 465 GLN B 612 REMARK 465 LEU B 613 REMARK 465 SER B 614 REMARK 465 PRO B 722 REMARK 465 LYS B 723 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 468 CG CD1 CD2 CE1 CE2 CZ REMARK 470 VAL A 487 CG1 CG2 REMARK 470 GLN A 493 CG CD OE1 NE2 REMARK 470 LYS A 522 CG CD CE NZ REMARK 470 GLN A 628 CG CD OE1 NE2 REMARK 470 ASP A 629 CG OD1 OD2 REMARK 470 LYS A 630 CG CD CE NZ REMARK 470 ARG A 682 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 687 CG CD CE NZ REMARK 470 PHE B 468 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LEU B 485 CG CD1 CD2 REMARK 470 ASN B 486 CG OD1 ND2 REMARK 470 VAL B 487 CG1 CG2 REMARK 470 THR B 488 OG1 CG2 REMARK 470 GLN B 493 CG CD OE1 NE2 REMARK 470 LYS B 522 CG CD CE NZ REMARK 470 GLN B 628 CG CD OE1 NE2 REMARK 470 LYS B 630 CG CD CE NZ REMARK 470 ARG B 682 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 687 CG CD CE NZ REMARK 470 LYS B 700 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 476 91.45 -160.99 REMARK 500 ARG A 509 80.45 -151.10 REMARK 500 ILE A 543 -64.49 -92.53 REMARK 500 ARG A 575 -9.82 73.11 REMARK 500 ASP A 576 43.72 -150.64 REMARK 500 GLU A 586 27.09 47.57 REMARK 500 LEU A 588 -13.15 -146.20 REMARK 500 SER A 616 74.43 -118.08 REMARK 500 ILE B 543 -64.02 -92.49 REMARK 500 ASP B 576 42.94 -157.07 REMARK 500 LEU B 588 -13.38 -147.31 REMARK 500 SER B 616 73.49 -118.54 REMARK 500 MET B 627 55.85 74.02 REMARK 500 GLN B 628 -73.56 -61.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 55J A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 55J B 801 DBREF 5CT7 A 445 723 UNP P15056 BRAF_HUMAN 445 723 DBREF 5CT7 B 445 723 UNP P15056 BRAF_HUMAN 445 723 SEQADV 5CT7 GLY A 443 UNP P15056 EXPRESSION TAG SEQADV 5CT7 SER A 444 UNP P15056 EXPRESSION TAG SEQADV 5CT7 GLY B 443 UNP P15056 EXPRESSION TAG SEQADV 5CT7 SER B 444 UNP P15056 EXPRESSION TAG SEQRES 1 A 281 GLY SER ASP SER SER ASP ASP TRP GLU ILE PRO ASP GLY SEQRES 2 A 281 GLN ILE THR VAL GLY GLN ARG ILE GLY SER GLY SER PHE SEQRES 3 A 281 GLY THR VAL TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA SEQRES 4 A 281 VAL LYS MET LEU ASN VAL THR ALA PRO THR PRO GLN GLN SEQRES 5 A 281 LEU GLN ALA PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS SEQRES 6 A 281 THR ARG HIS VAL ASN ILE LEU LEU PHE MET GLY TYR SER SEQRES 7 A 281 THR LYS PRO GLN LEU ALA ILE VAL THR GLN TRP CYS GLU SEQRES 8 A 281 GLY SER SER LEU TYR HIS HIS LEU HIS ILE ILE GLU THR SEQRES 9 A 281 LYS PHE GLU MET ILE LYS LEU ILE ASP ILE ALA ARG GLN SEQRES 10 A 281 THR ALA GLN GLY MET ASP TYR LEU HIS ALA LYS SER ILE SEQRES 11 A 281 ILE HIS ARG ASP LEU LYS SER ASN ASN ILE PHE LEU HIS SEQRES 12 A 281 GLU ASP LEU THR VAL LYS ILE GLY ASP PHE GLY LEU ALA SEQRES 13 A 281 THR VAL LYS SER ARG TRP SER GLY SER HIS GLN PHE GLU SEQRES 14 A 281 GLN LEU SER GLY SER ILE LEU TRP MET ALA PRO GLU VAL SEQRES 15 A 281 ILE ARG MET GLN ASP LYS ASN PRO TYR SER PHE GLN SER SEQRES 16 A 281 ASP VAL TYR ALA PHE GLY ILE VAL LEU TYR GLU LEU MET SEQRES 17 A 281 THR GLY GLN LEU PRO TYR SER ASN ILE ASN ASN ARG ASP SEQRES 18 A 281 GLN ILE ILE PHE MET VAL GLY ARG GLY TYR LEU SER PRO SEQRES 19 A 281 ASP LEU SER LYS VAL ARG SER ASN CYS PRO LYS ALA MET SEQRES 20 A 281 LYS ARG LEU MET ALA GLU CYS LEU LYS LYS LYS ARG ASP SEQRES 21 A 281 GLU ARG PRO LEU PHE PRO GLN ILE LEU ALA SER ILE GLU SEQRES 22 A 281 LEU LEU ALA ARG SER LEU PRO LYS SEQRES 1 B 281 GLY SER ASP SER SER ASP ASP TRP GLU ILE PRO ASP GLY SEQRES 2 B 281 GLN ILE THR VAL GLY GLN ARG ILE GLY SER GLY SER PHE SEQRES 3 B 281 GLY THR VAL TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA SEQRES 4 B 281 VAL LYS MET LEU ASN VAL THR ALA PRO THR PRO GLN GLN SEQRES 5 B 281 LEU GLN ALA PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS SEQRES 6 B 281 THR ARG HIS VAL ASN ILE LEU LEU PHE MET GLY TYR SER SEQRES 7 B 281 THR LYS PRO GLN LEU ALA ILE VAL THR GLN TRP CYS GLU SEQRES 8 B 281 GLY SER SER LEU TYR HIS HIS LEU HIS ILE ILE GLU THR SEQRES 9 B 281 LYS PHE GLU MET ILE LYS LEU ILE ASP ILE ALA ARG GLN SEQRES 10 B 281 THR ALA GLN GLY MET ASP TYR LEU HIS ALA LYS SER ILE SEQRES 11 B 281 ILE HIS ARG ASP LEU LYS SER ASN ASN ILE PHE LEU HIS SEQRES 12 B 281 GLU ASP LEU THR VAL LYS ILE GLY ASP PHE GLY LEU ALA SEQRES 13 B 281 THR VAL LYS SER ARG TRP SER GLY SER HIS GLN PHE GLU SEQRES 14 B 281 GLN LEU SER GLY SER ILE LEU TRP MET ALA PRO GLU VAL SEQRES 15 B 281 ILE ARG MET GLN ASP LYS ASN PRO TYR SER PHE GLN SER SEQRES 16 B 281 ASP VAL TYR ALA PHE GLY ILE VAL LEU TYR GLU LEU MET SEQRES 17 B 281 THR GLY GLN LEU PRO TYR SER ASN ILE ASN ASN ARG ASP SEQRES 18 B 281 GLN ILE ILE PHE MET VAL GLY ARG GLY TYR LEU SER PRO SEQRES 19 B 281 ASP LEU SER LYS VAL ARG SER ASN CYS PRO LYS ALA MET SEQRES 20 B 281 LYS ARG LEU MET ALA GLU CYS LEU LYS LYS LYS ARG ASP SEQRES 21 B 281 GLU ARG PRO LEU PHE PRO GLN ILE LEU ALA SER ILE GLU SEQRES 22 B 281 LEU LEU ALA ARG SER LEU PRO LYS HET 55J A 801 37 HET 55J B 801 37 HETNAM 55J 1-METHYL-5-({2-[5-(TRIFLUOROMETHYL)-1H-IMIDAZOL-2- HETNAM 2 55J YL]PYRIDIN-4-YL}OXY)-N-[4-(TRIFLUOROMETHYL)PHENYL]-1H- HETNAM 3 55J BENZIMIDAZOL-2-AMINE FORMUL 3 55J 2(C24 H16 F6 N6 O) HELIX 1 AA1 THR A 491 ARG A 506 1 16 HELIX 2 AA2 LEU A 537 ILE A 543 1 7 HELIX 3 AA3 GLU A 549 LYS A 570 1 22 HELIX 4 AA4 LYS A 578 ASN A 580 5 3 HELIX 5 AA5 ALA A 621 MET A 627 1 7 HELIX 6 AA6 SER A 634 GLY A 652 1 19 HELIX 7 AA7 ASN A 661 ARG A 671 1 11 HELIX 8 AA8 ASP A 677 VAL A 681 5 5 HELIX 9 AA9 PRO A 686 LEU A 697 1 12 HELIX 10 AB1 LYS A 700 ARG A 704 5 5 HELIX 11 AB2 LEU A 706 SER A 720 1 15 HELIX 12 AB3 THR B 491 ARG B 506 1 16 HELIX 13 AB4 LEU B 537 ILE B 543 1 7 HELIX 14 AB5 GLU B 549 LYS B 570 1 22 HELIX 15 AB6 LYS B 578 ASN B 580 5 3 HELIX 16 AB7 ALA B 621 MET B 627 1 7 HELIX 17 AB8 SER B 634 GLY B 652 1 19 HELIX 18 AB9 ASN B 661 ARG B 671 1 11 HELIX 19 AC1 ASP B 677 VAL B 681 5 5 HELIX 20 AC2 PRO B 686 LEU B 697 1 12 HELIX 21 AC3 LYS B 700 ARG B 704 5 5 HELIX 22 AC4 LEU B 706 SER B 720 1 15 SHEET 1 AA1 5 THR A 458 SER A 465 0 SHEET 2 AA1 5 GLY A 469 LYS A 475 -1 O LYS A 473 N GLN A 461 SHEET 3 AA1 5 ASP A 479 LEU A 485 -1 O VAL A 480 N GLY A 474 SHEET 4 AA1 5 ALA A 526 GLN A 530 -1 O THR A 529 N ALA A 481 SHEET 5 AA1 5 PHE A 516 SER A 520 -1 N SER A 520 O ALA A 526 SHEET 1 AA2 3 GLY A 534 SER A 536 0 SHEET 2 AA2 3 ILE A 582 HIS A 585 -1 O LEU A 584 N SER A 535 SHEET 3 AA2 3 THR A 589 ILE A 592 -1 N THR A 589 O HIS A 585 SHEET 1 AA3 5 THR B 458 SER B 465 0 SHEET 2 AA3 5 THR B 470 LYS B 475 -1 O VAL B 471 N ILE B 463 SHEET 3 AA3 5 ASP B 479 MET B 484 -1 O VAL B 480 N GLY B 474 SHEET 4 AA3 5 ALA B 526 GLN B 530 -1 O ILE B 527 N LYS B 483 SHEET 5 AA3 5 PHE B 516 SER B 520 -1 N SER B 520 O ALA B 526 SHEET 1 AA4 3 GLY B 534 SER B 536 0 SHEET 2 AA4 3 ILE B 582 HIS B 585 -1 O LEU B 584 N SER B 535 SHEET 3 AA4 3 THR B 589 ILE B 592 -1 O THR B 589 N HIS B 585 CISPEP 1 LYS A 522 PRO A 523 0 1.26 CISPEP 2 LYS B 522 PRO B 523 0 2.21 SITE 1 AC1 20 ILE A 463 VAL A 471 ALA A 481 LYS A 483 SITE 2 AC1 20 GLU A 501 ILE A 513 LEU A 514 ILE A 527 SITE 3 AC1 20 THR A 529 GLN A 530 TRP A 531 CYS A 532 SITE 4 AC1 20 GLY A 534 LEU A 567 HIS A 574 PHE A 583 SITE 5 AC1 20 ILE A 592 GLY A 593 ASP A 594 PHE A 595 SITE 1 AC2 21 ILE B 463 VAL B 471 ALA B 481 LYS B 483 SITE 2 AC2 21 GLU B 501 LEU B 505 THR B 508 ILE B 513 SITE 3 AC2 21 LEU B 514 ILE B 527 THR B 529 GLN B 530 SITE 4 AC2 21 TRP B 531 CYS B 532 LEU B 567 HIS B 574 SITE 5 AC2 21 PHE B 583 ILE B 592 GLY B 593 ASP B 594 SITE 6 AC2 21 PHE B 595 CRYST1 109.380 109.380 158.130 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009142 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009142 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006324 0.00000